Contrasting contributions of TNF from distinct cellular sources in arthritis

OBJECTIVES: Neutralisation of tumour necrosis factor (TNF) is widely used as a therapy for rheumatoid arthritis (RA). However, this therapy is only effective in less than a half of patients and is associated with several side effects. We hypothesised that TNF may possess non-redundant protective and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kruglov, Andrey, Drutskaya, Marina, Schlienz, Dirk, Gorshkova, Ekaterina, Kurz, Katharina, Morawietz, Lars, Nedospasov, Sergei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569389/
https://www.ncbi.nlm.nih.gov/pubmed/32796044
http://dx.doi.org/10.1136/annrheumdis-2019-216068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569389/
https://www.ncbi.nlm.nih.gov/pubmed/32796044
http://dx.doi.org/10.1136/annrheumdis-2019-216068

Ejemplares similares